Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Puhr M et al. – SOCS–3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration–resistant tumors. SOCS–3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways.

Related Articles

Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation
Experimental Hematology, 11/25/09    Relevance Score: 67%

Feedback Regulation of Mitochondria by Caspase-9 in the B Cell Receptor-Mediated Apoptosis
Scandinavian Journal of Immunology, 11/23/09    Relevance Score: 67%

Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Proceedings of the National Academy of Sciences of the United States of America, 11/18/09    Relevance Score: 67%

Deregulation of cell-death pathways as the cornerstone of skin diseases
Clinical and Experimental Dermatology, 11/03/09    Relevance Score: 67%

Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway
Annals of Oncology, 11/16/09    Relevance Score: 66%

Today in Renal/Urologic...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address